HCPCS G2083: Esketamine visitMedicare rate & RVUs in Oregon
Reports an established-patient office or outpatient visit for supervised esketamine treatment when the administered dose exceeds 56 mg, including observation.
Medicare pays $1,350.06–$1,503.52 for G2083 in the office in Oregon, from Rest Of Oregon to Portland. Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
On this page 9 sections
What G2083 covers
G2083 covers an established-patient office or outpatient encounter for esketamine treatment when the dose exceeds 56 mg. A physician or other qualified health care professional supervises the treatment, during which the patient self-administers intranasal esketamine under clinical supervision. This service is commonly provided in a clinic treating adults with treatment-resistant depression. The code includes the esketamine and two hours of post-administration observation.
Choose G2083 based on the total dose administered: it is for doses above 56 mg, while G2082 is for 56 mg or less. The record should support established-patient status, the clinical evaluation, the administered dose, supervision, and the observation. The visit, esketamine provision, and two-hour observation are packaged in the code; do not separately report those same services as though they were independent services.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where G2083 pays more and less in Oregon
| Payment locality | Office | Facility |
|---|---|---|
| Portland | $1,503.52 | $31.43 |
| Rest Of Oregon | $1,350.06 | $30.35 |
How the G2083 rate is calculated
Each of G2083’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · G2083
RVUs × geographic indexes × conversion factor
Swap in your local Medicare rate.
Work 0.70Practice expense 39.83Malpractice 0.07
All indexes start at 1.000 (the national rate). Enter a ZIP or drag a slider.
Payment rules and modifiers for G2083
G2083 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · G2083
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
Non-facility (office) rate · national
$1,356.08
The facility rate would be $31.06 (+$1,325.02). In a facility, the facility bills its own costs separately.
G2083 compared with similar codes
Compare codes
G2083 vs G2082 vs 99213 vs 99214: national Medicare rates
Swap in your local Medicare rate.
How to choose
- G2082Esketamine visit
- G2082 applies to a supervised esketamine dose of 56 mg or less; G2083 applies above 56 mg. Both include the visit, esketamine provision, and two-hour observation.
- 99213Office visit
- 99213 reports an established-patient E/M service without the bundled esketamine treatment. G2083 includes E/M as part of the supervised treatment visit.
- 99214Office visit
- 99214 reports an established-patient E/M service without the bundled esketamine treatment. Use G2083 for the qualifying supervised esketamine visit rather than separately reporting its included E/M work.
G2083 billing questions
When should the clinic use G2083 instead of G2082?
Use G2083 when the esketamine dose administered is more than 56 mg. Use G2082 for a dose of 56 mg or less.
Does G2083 include the esketamine and observation?
Yes. The service includes provision of esketamine and two hours of post-administration observation.
Can the clinic bill a separate E/M code for the same visit?
The E/M service is included in G2083. Do not separately report the same evaluation and management work.
Is the code selected based on observation time?
No. The distinguishing threshold is the administered esketamine dose, not a longer observation period.
What dose documentation supports G2083?
Document the total esketamine dose administered, along with the evaluation, supervision, and post-administration observation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets
Put G2083 and the rest of your codes on one sheet
Build a fee sheet from your own code list at your locality, put your payer contracts beside Medicare, and see what changed each quarter.
Build my fee sheetOr price your code list free →